Healthpeak Properties (NYSE:PEAK) announced its earnings results on Tuesday. The company reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.12), MarketWatch Earnings reports. The business had revenue of $446.26 million during the quarter, compared to analyst estimates of $526.89 million. Healthpeak Properties had a net margin of 13.46% and a return on equity of 4.19%. The business’s revenue was up 18.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.54 earnings per share. Healthpeak Properties updated its FY 2021 guidance to 1.530-1.610 EPS and its FY21 guidance to $0.98-1.06 EPS.
Shares of PEAK traded down $0.12 during trading hours on Tuesday, reaching $34.03. 2,677,585 shares of the company’s stock traded hands, compared to its average volume of 3,395,919. The firm has a market capitalization of $18.34 billion, a price-to-earnings ratio of 56.72, a P/E/G ratio of 7.73 and a beta of 0.72. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.71 and a quick ratio of 0.71. Healthpeak Properties has a twelve month low of $20.56 and a twelve month high of $34.58. The business’s fifty day simple moving average is $32.84 and its two-hundred day simple moving average is $30.67.
The business also recently announced a quarterly dividend, which will be paid on Friday, May 21st. Shareholders of record on Monday, May 10th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 3.53%. The ex-dividend date of this dividend is Friday, May 7th. Healthpeak Properties’s dividend payout ratio is presently 68.18%.
PEAK has been the topic of a number of recent research reports. Morgan Stanley lifted their target price on shares of Healthpeak Properties from $29.00 to $30.00 and gave the company an “equal weight” rating in a report on Monday, March 22nd. Bank of America upgraded shares of Healthpeak Properties from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $34.00 to $35.50 in a research report on Tuesday, March 30th. Capital One Financial upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating in a research report on Wednesday, January 20th. Wells Fargo & Company lifted their price objective on shares of Healthpeak Properties from $25.00 to $32.00 in a research report on Wednesday, April 14th. Finally, Mizuho lifted their price objective on shares of Healthpeak Properties from $29.00 to $32.00 and gave the company a “neutral” rating in a research report on Tuesday, February 9th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $30.77.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.
Featured Article: Find a Trading Strategy That Works
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.